Effect Posterior QLB on Atelectasis
Sponsor
Zonguldak Bulent Ecevit University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04830280
Collaborator
(none)
2
1
2
7
0.3
Study Details
Study Description
Brief Summary
We aimed to investigate the effect of posterior quadratus lumborum block on postoperative atelectasis in inguinal hernia surgery in pediatric patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
2 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
The Effect of Ultrasound-guided Posterior Quadratus Lumborum Block on Atelectasis in Pediatric Patients
Actual Study Start Date
:
Mar 1, 2021
Anticipated Primary Completion Date
:
Aug 31, 2021
Anticipated Study Completion Date
:
Sep 30, 2021
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Posterior quadratus lumborum block
|
Procedure: posterior quadratus lumborum block
administration local anesthetic solution between the middle layer of the thoracolumbar fascia and QL muscle at the posterior edge of the quadratus lumborum muscle
|
Sham Comparator: control group
|
Procedure: posterior quadratus lumborum block
administration local anesthetic solution between the middle layer of the thoracolumbar fascia and QL muscle at the posterior edge of the quadratus lumborum muscle
|
Outcome Measures
Primary Outcome Measures
- lung ultrasound score [up to 1 hour after surgery]
atelectasis
Secondary Outcome Measures
- pain scores [up to 6 hour after surgery]
Flacc scores
Eligibility Criteria
Criteria
Ages Eligible for Study:
0 Years
to 2 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
under 2 years old,
-
ASA I-II risk group
-
Patients who underwent an inguinal hernia operation under general anesthesia, posterior quadratus lumborum block for postoperative analgesia or pain treatment with conventional method
-
Patients whose informed consent was read and approval was obtained from him and his guardian
Exclusion Criteria:
-
who do not want to participate in the study,
-
ASA III-IV-V patients
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Zonguldak Bülent Ecevit University Medicine Faculty | Zonguldak | Kozlu | Turkey | 67600 |
Sponsors and Collaborators
- Zonguldak Bulent Ecevit University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Çağdaş Baytar,
medical doctor,
Zonguldak Bulent Ecevit University
ClinicalTrials.gov Identifier:
NCT04830280
Other Study ID Numbers:
- 2021/03-11
First Posted:
Apr 5, 2021
Last Update Posted:
Jun 2, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Çağdaş Baytar,
medical doctor,
Zonguldak Bulent Ecevit University
Additional relevant MeSH terms: